Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioregenx (BRGX) FCF Margin (2022 - 2025)

Bioregenx (BRGX) has 4 years of FCF Margin data on record, last reported at 15.28% in Q3 2025.

  • For Q3 2025, FCF Margin fell 1004.0% year-over-year to 15.28%; the TTM value through Sep 2025 reached 2.49%, up 2675.0%, while the annual FY2024 figure was 21.95%, 2247.0% up from the prior year.
  • FCF Margin reached 15.28% in Q3 2025 per BRGX's latest filing, down from 0.72% in the prior quarter.
  • Across five years, FCF Margin topped out at 7.32% in Q1 2025 and bottomed at 7681.95% in Q3 2023.
  • Average FCF Margin over 4 years is 568.25%, with a median of 36.23% recorded in 2023.
  • Peak YoY movement for FCF Margin: tumbled -762649bps in 2023, then surged 767672bps in 2024.
  • A 4-year view of FCF Margin shows it stood at 48.96% in 2022, then grew by 26bps to 36.23% in 2023, then skyrocketed by 93bps to 2.47% in 2024, then plummeted by -519bps to 15.28% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 15.28% in Q3 2025, 0.72% in Q2 2025, and 7.32% in Q1 2025.